GO:0140738 NLRP6 inflammasome complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140738 defines the NLRP6 inflammasome complex, a cellular component composed of NLRP6, PYCARD/ASC, and caspase-1 or caspase-4/caspase-11.
• NLRP6 is an enigmatic inflammasome sensor that assembles in response to microbial and danger signals, often in intestinal epithelial cells.
• The complex drives caspase-1 activation, IL-18/IL-1beta maturation, and pyroptosis, shaping host defense and intestinal homeostasis.
• NLRP6 inflammasome activity is linked to colitis, colorectal cancer, and metabolic disease, making it a therapeutic target.
• Studying GO:0140738 requires knockout, knock-in, and tagged cell models to dissect assembly, signaling, and disease mechanisms.
• CRISPR-based models (KO, point mutation, knock-in, overexpression) are essential for causal gene validation in NLRP6 inflammasome research.
Description
The NLRP6 inflammasome complex (GO:0140738) is a multi-protein intracellular assembly that serves as a platform for inflammatory caspase activation. It is defined by the presence of NLRP6, the adaptor PYCARD/ASC, and either caspase-1 or caspase-4/caspase-11, and it functions as a sensor of microbial and danger-associated signals in barrier tissues. Since its discovery, NLRP6 has been recognized as an enigmatic inflammasome due to its unconventional activation and tissue-specific roles. Understanding this complex is critical because it bridges innate immunity, host-microbiota interactions, and epithelial cell fate decisions. Researchers studying GO:0140738 aim to define its assembly rules, signaling outputs, and contributions to disease, which requires precise genetic models and functional assays. This article synthesizes current knowledge from QuickGO and verified PubMed literature to provide a research-grade overview of the NLRP6 inflammasome complex, its components, regulatory mechanisms, and experimental approaches.
NLRP6 inflammasome complex At A Glance
| GO ID | GO:0140738 |
|---|---|
| GO term | NLRP6 inflammasome complex |
| Ontology | cellular_component |
| Synonym | None |
| Major function | Serves as a platform for caspase-1 or caspase-4/caspase-11 activation, leading to IL-18/IL-1beta maturation and pyroptosis. |
| Key components | NLRP6, PYCARD/ASC, caspase-1, caspase-4/caspase-11. |
| Cellular location | Cytosol, often associated with the plasma membrane or endosomes in epithelial cells. |
| Tissue expression | Predominantly in intestinal epithelial cells, hepatocytes, and some immune cells. |
| Associated diseases | Colitis, colorectal cancer, metabolic syndrome, and non-alcoholic fatty liver disease. |
What Is GO:0140738?
The NLRP6 inflammasome complex is a cellular component defined by the Gene Ontology as an inflammasome complex that consists of NLRP6, PYCARD/ASC, and caspase-1 or caspase-4/caspase-11. It is a cytosolic multiprotein oligomer that assembles upon detection of specific microbial or endogenous danger signals, leading to caspase activation and inflammatory cytokine processing.
Why Is NLRP6 inflammasome complex Important in Cell Biology?
The NLRP6 inflammasome complex is important because it is a key regulator of intestinal homeostasis, host defense against pathogens, and tumorigenesis. Dysregulation of NLRP6 signaling has been linked to inflammatory bowel diseases, colorectal cancer, and metabolic disorders, making it a potential therapeutic target. Understanding its assembly and function at the molecular level is essential for developing interventions that modulate inflammasome activity in disease.
• Maintains intestinal epithelial barrier integrity and regulates mucus secretion.
• Controls host defense against bacterial and viral pathogens through IL-18 production.
• Modulates the gut microbiota composition and host-microbe interactions.
• Plays a dual role in cancer: protective in colitis-associated cancer but potentially tumor-promoting in some contexts.
• Contributes to metabolic inflammation and non-alcoholic fatty liver disease.
• Serves as a model for studying unconventional inflammasome activation mechanisms.
• Involved in pyroptosis, a lytic cell death pathway important for pathogen clearance.
• Genetic variants in NLRP6 are associated with susceptibility to inflammatory diseases.
• Provides a target for drug discovery aimed at modulating innate immunity.
• Requires advanced CRISPR models to dissect its cell-type-specific functions.
What Happens During NLRP6 inflammasome complex?
Signal Recognition and Priming
In simple terms: The cell gets ready to respond to danger signals by increasing NLRP6 levels.
NLRP6 inflammasome activation begins with priming signals, such as microbial ligands or cytokines, that upregulate NLRP6 expression and post-translational modifications. This priming step is often mediated by NF-kB and other transcription factors, preparing the cell for assembly.
Complex Assembly
In simple terms: NLRP6, ASC, and caspases come together to form a molecular platform.
Upon activation, NLRP6 oligomerizes and recruits PYCARD/ASC via pyrin domain interactions, which in turn recruits pro-caspase-1 or pro-caspase-4/11 through CARD-CARD interactions. This assembly forms a high-molecular-weight complex that serves as an activation platform.
Caspase Activation and Cytokine Processing
In simple terms: The assembled complex activates caspases that cut pro-inflammatory cytokines into their active forms.
The NLRP6 inflammasome promotes autoproteolytic activation of caspase-1, which then cleaves pro-IL-18 and pro-IL-1beta into their mature forms. In non-canonical pathways, caspase-4/11 can be activated directly, leading to pyroptosis.
Pyroptosis and Cell Fate
In simple terms: Activated caspases can trigger a form of programmed cell death that alerts the immune system.
Caspase-1 or caspase-4/11 activation can cleave gasdermin D, forming membrane pores that induce pyroptosis, a lytic cell death that releases inflammatory contents. This process is critical for pathogen clearance but can also contribute to tissue damage in chronic inflammation.
Key Genes Involved in GO:0140738 NLRP6 inflammasome complex
The NLRP6 inflammasome complex involves a core set of genes and proteins that mediate its assembly, signaling, and regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP6 | Sensor and scaffold; nucleates complex assembly | Central to GO:0140738; knockout models show impaired IL-18 production. |
| PYCARD | Adaptor linking NLRP6 to caspases | Essential for inflammasome assembly; KO abolishes signaling. |
| CASP1 | Effector caspase; cleaves IL-18/IL-1beta | Key readout of NLRP6 activity; KO blocks cytokine maturation. |
| CASP4 | Non-canonical caspase in humans; activates pyroptosis | Relevant in epithelial cells; KO reduces pyroptosis. |
| CASP11 | Murine homolog of caspase-4 | Used in mouse models to study non-canonical NLRP6 signaling. |
| IL18 | Pro-inflammatory cytokine processed by caspase-1 | Biomarker of NLRP6 activity; KO mice show reduced inflammation. |
| IL1B | Pro-inflammatory cytokine processed by caspase-1 | Readout of inflammasome activation; KO reduces fever and inflammation. |
| GSDMD | Pore-forming protein downstream of caspases | Mediates pyroptosis; KO prevents cell lysis. |
| NFKB1 | Transcription factor for priming signals | Regulates NLRP6 expression; KO reduces priming. |
| TXNIP | Redox regulator interacting with NLRP6 | Modulates inflammasome activation; KO alters ROS responses. |
| DHX15 | RNA helicase involved in NLRP6 signaling | Facilitates complex assembly; KO impairs IL-18 production. |
| MAVS | Mitochondrial antiviral signaling protein | Cross-talk with NLRP6 in antiviral responses; KO affects interferon. |
| ATG16L1 | Autophagy-related protein | Regulates NLRP6 degradation; KO increases inflammasome activity. |
| NLRP3 | Related inflammasome sensor | Comparative studies; KO distinguishes pathways. |
| AIM2 | Related inflammasome sensor | Comparative studies; KO distinguishes pathways. |
| CARD8 | Inflammasome sensor in humans | Potential redundancy; KO studies. |
| PYDC1 | Decoy protein regulating ASC | Modulates NLRP6 assembly; overexpression studies. |
| TRAF3 | E3 ubiquitin ligase | Regulates NLRP6 ubiquitination; KO affects stability. |
How Is NLRP6 inflammasome complex Regulated?
NLRP6 inflammasome complex activity is tightly regulated at multiple levels. Priming signals via NF-kB upregulate NLRP6 expression. Post-translational modifications, including ubiquitination by TRAF3 and phosphorylation, control NLRP6 stability and assembly. Autophagy proteins such as ATG16L1 negatively regulate the inflammasome by targeting it for degradation. Additionally, decoy proteins like PYDC1 can interfere with ASC recruitment, dampening signaling. Microbial metabolites, such as taurine and histamine, also modulate NLRP6 activity, linking the microbiota to inflammasome regulation.
NLRP6 inflammasome complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP6 | Colitis and inflammatory bowel disease | NLRP6 KO mice; DSS-induced colitis model. |
| NLRP6 | Colorectal cancer | AOM/DSS model in NLRP6 KO mice. |
| CASP1 | Pyroptosis and cytokine storm | Caspase-1 KO mice; LPS challenge. |
| IL18 | Intestinal barrier dysfunction | IL-18 KO mice; infection models. |
| GSDMD | Pyroptosis-related tissue damage | GSDMD KO mice; sepsis models. |
NLRP6 Inflammasome in Intestinal Inflammation and Colitis
NLRP6 inflammasome deficiency leads to exacerbated colitis in mouse models, characterized by increased epithelial damage and reduced IL-18 production. Polymorphisms in NLRP6 have been associated with inflammatory bowel disease susceptibility in humans. The complex maintains intestinal homeostasis by promoting mucus secretion and antimicrobial peptide production.
NLRP6 Inflammasome in Colorectal Cancer
NLRP6 plays a dual role in colorectal cancer: it protects against colitis-associated cancer by controlling inflammation and epithelial repair, but in some contexts, it may promote tumorigenesis through IL-18-dependent pathways. Loss of NLRP6 increases tumor burden in azoxymethane/dextran sulfate sodium models. The complex also scaffolds DNA damage response proteins, linking inflammasome signaling to genome stability.
NLRP6 Inflammasome in Metabolic and Liver Diseases
NLRP6 inflammasome activity is implicated in non-alcoholic fatty liver disease and metabolic syndrome, where it modulates hepatic inflammation and lipid metabolism. NLRP6 deficiency worsens steatohepatitis in mice fed a high-fat diet. The complex also influences gut-liver axis communication through microbiota-derived signals.
From NLRP6 inflammasome complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NLRP6 loss affect IL-18 production? | NLRP6 knockout cell line (e.g., HCT116). |
| Does a point mutation in NLRP6 alter assembly? | NLRP6 point-mutant knock-in via CRISPR. |
| Can we track NLRP6 complex formation in live cells? | Tagged knock-in of NLRP6 with fluorescent protein. |
| Does overexpression of NLRP6 enhance pyroptosis? | NLRP6 overexpression lentiviral system. |
| Which genes regulate NLRP6 stability? | CRISPR library screening in NLRP6 reporter cells. |
| Does caspase-4 compensate for caspase-1 loss? | Double knockout of CASP1 and CASP4. |
How to Study the NLRP6 inflammasome complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Caspase-1 cleavage and IL-18 maturation | Assessing NLRP6 inflammasome activation. |
| Co-immunoprecipitation | Protein-protein interactions in the complex | Detecting NLRP6-ASC association. |
| Native PAGE | High-molecular-weight complex formation | Visualizing inflammasome oligomerization. |
| RNA-seq | Transcriptional changes upon NLRP6 loss | Identifying downstream pathways. |
| Proteomics | Global protein abundance and modifications | Discovering novel regulators. |
| CRISPR library screening | Genes affecting NLRP6 activity | Unbiased modifier screens. |
| Fluorescence microscopy | Inflammasome speck formation | Live-cell imaging of assembly. |
| Flow cytometry | Pyroptosis and cytokine production | Quantifying cell death and IL-18. |
Genetic Knockout and Knock-in Models
CRISPR-Cas9 knockout of NLRP6, PYCARD, or CASP1 in cell lines and mice is used to dissect the requirement for each component in inflammasome assembly and signaling. Knock-in of tagged NLRP6 allows visualization of complex formation and trafficking.
Biochemical Assays for Inflammasome Activation
Immunoblotting for caspase-1 cleavage, IL-18 maturation, and gasdermin D processing is standard for assessing NLRP6 inflammasome activity. Co-immunoprecipitation and native PAGE can detect complex assembly.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics of NLRP6-deficient cells reveal downstream transcriptional and post-translational changes, identifying novel regulators and biomarkers. CRISPR library screening combined with these readouts can uncover genetic modifiers.
Imaging and Flow Cytometry
Fluorescence microscopy and flow cytometry using fluorescently tagged NLRP6 or ASC can monitor inflammasome speck formation and pyroptosis in real time. These methods are valuable for high-content screening.
How CRISPR Can Be Used to Study GO:0140738 NLRP6 inflammasome complex
Knockout
CRISPR knockout of NLRP6, PYCARD, or CASP1 is used to abolish inflammasome function and study its role in disease models. Knockout cell lines are essential for validating antibody specificity and for rescue experiments.
Point Mutation
Point mutations in NLRP6 (e.g., in the pyrin domain) can be introduced via CRISPR to dissect domain-specific functions and identify residues critical for ASC recruitment. Such models help distinguish assembly defects from signaling defects.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins into the endogenous NLRP6 locus enables tracking of complex formation and localization under physiological expression levels. This approach avoids artifacts from overexpression.
Overexpression
Overexpression of NLRP6 or its mutants via lentiviral vectors is used to test gain-of-function effects, such as enhanced pyroptosis or cytokine production. Overexpression models are useful for screening inhibitors.
How EDITGENE Supports NLRP6 inflammasome complex Research
Researchers studying NLRP6 inflammasome complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, signaling, or disease pathogenesis. This requires precise genetic manipulation and functional validation, which can be achieved through CRISPR-based cell models and screening services.
Contact EDITGENE today to design your custom CRISPR model for NLRP6 inflammasome complex research.
Frequently Asked Questions About NLRP6 inflammasome complex
What is the NLRP6 inflammasome complex?
The NLRP6 inflammasome complex (GO:0140738) is a multiprotein assembly of NLRP6, PYCARD/ASC, and caspase-1 or caspase-4/11 that activates inflammatory caspases in response to microbial and danger signals.
What genes are involved in the NLRP6 inflammasome complex?
Core genes include NLRP6, PYCARD, CASP1, CASP4, and CASP11, along with downstream effectors like IL18, IL1B, and GSDMD.
Where is the NLRP6 inflammasome complex located?
It is a cytosolic complex, often associated with membranes in intestinal epithelial cells, hepatocytes, and some immune cells.
What diseases are linked to NLRP6 inflammasome dysfunction?
Dysregulation is linked to colitis, colorectal cancer, metabolic syndrome, and non-alcoholic fatty liver disease.
How is the NLRP6 inflammasome activated?
Activation involves priming by NF-kB, oligomerization of NLRP6, recruitment of ASC and caspases, and subsequent caspase activation.
What is the role of NLRP6 in cancer?
NLRP6 can be protective in colitis-associated cancer but may promote tumorigenesis in some contexts through IL-18 and DNA damage response scaffolding.
How can I study NLRP6 inflammasome assembly?
Use CRISPR knockout, knock-in of tagged NLRP6, co-immunoprecipitation, native PAGE, and imaging to monitor complex formation.
What cell models are available for NLRP6 research?
Common models include HCT116, Caco-2, and HEK293T cells with CRISPR modifications, as well as mouse models.
Does NLRP6 interact with the gut microbiota?
Yes, NLRP6 inflammasome activity is modulated by microbial metabolites and influences microbiota composition.
What are the downstream effects of NLRP6 inflammasome activation?
Activation leads to caspase-1-mediated maturation of IL-18 and IL-1beta, and gasdermin D-dependent pyroptosis.
Conclusion
The NLRP6 inflammasome complex (GO:0140738) is a critical innate immune sensor that integrates microbial and danger signals to regulate inflammation, cell death, and tissue homeostasis. Its roles in intestinal inflammation, cancer, and metabolic disease make it a compelling target for therapeutic intervention. Advances in CRISPR-based models and screening technologies are accelerating our understanding of its assembly and regulation. Continued research into this enigmatic inflammasome will likely reveal new strategies for modulating innate immunity in human disease.
References
- 1. Triantafilou K. 2021. Enigmatic inflammasomes.. Immunology 162(3):249-251 PMID: 33590488
- 2. Ghimire L et al.. 2020. The NLRP6 inflammasome in health and disease.. Mucosal Immunol 13(3):388-398 PMID: 31988468
- 3. Shen C et al.. 2024. Inflammasome protein scaffolds the DNA damage complex during tumor development.. Nat Immunol 25(11):2085-2096 PMID: 39402152
- 4. Li R et al.. 2022. The latest breakthrough on NLRP6 inflammasome.. Precis Clin Med 5(3):pbac022 PMID: 36211635
- 5. Pandey A et al.. 2025. Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis.. Immunol Rev 329(1):e13406 PMID: 39351983
- 6. Janowski AM et al.. 2016. Atypical Inflammasomes.. Methods Mol Biol 1417:45-62 PMID: 27221480
- 7. Karki R et al.. 2017. Inflammasomes and Cancer.. Cancer Immunol Res 5(2):94-99 PMID: 28093447
- 8. Venuprasad K et al.. 2021. NLRP6 in host defense and intestinal inflammation.. Cell Rep 35(4):109043 PMID: 33910012
